LOS ANGELES — Oncology specialists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, can now provide leading-edge clinical guidance to patients living in Southeast Asia through a second opinion collaboration agreement with the Healthway Cancer Care Hospital, the first comprehensive cancer hospital in the Philippines. This strategic integration of services will enhance Southeast Asia’s access to world-class cancer care by leveraging the strengths of both institutions.
Credit: Photo credit: City of Hope
LOS ANGELES — Oncology specialists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, can now provide leading-edge clinical guidance to patients living in Southeast Asia through a second opinion collaboration agreement with the Healthway Cancer Care Hospital, the first comprehensive cancer hospital in the Philippines. This strategic integration of services will enhance Southeast Asia’s access to world-class cancer care by leveraging the strengths of both institutions.
“With advances in precision medicine, we have learned that cancer is not one disease but hundreds, with unique variants that can be targeted for treatment,” said Harlan Levine, M.D., president of health innovation and policy at City of Hope. “The pace of innovation in oncology heightens the need for patients to have access to the appropriate subspecialists who can support making the most accurate diagnosis and developing a targeted treatment program specific to the cancer type. Through this collaboration, we’re combining the expertise of both institutions, providing enhanced access to specialized cancer care and helping make hope a reality for all touched by cancer.”
As one of the United States’ top 5 hospitals for cancer care, City of Hope National Medical Center is expanding its ability to make a meaningful impact in the lives of patients, families and communities globally. City of Hope has the world’s leading experts across a range of complex cancers. With more than 550 physicians and 1,000 researchers and scientists working together, City of Hope is able to make new research breakthroughs and lifesaving treatments accessible to everyone touched by cancer regardless of if they live near a City of Hope location.
Second opinions from City of Hope subspecialists will be delivered through real-time physician-to-physician consultations and reports that provide expert cancer care treatment approaches in a convenient, written format. This initiative reflects the shared commitment of both institutions to provide comprehensive, high-quality cancer care.
The agreement is with the Healthway Cancer Care Hospital located within the ARCA South development in Taguig City. This is a 100-bed facility dedicated to providing accessible and quality cancer services to Filipinos. As part of AC Health, a subsidiary of Ayala Corporation, the Healthway Cancer Care Hospital benefits from the extensive experience and resources of the Philippines’ oldest and largest conglomerate. This affiliation with Ayala Corporation enhances its ability to provide high-quality care and access to advanced medical technologies.
“I am delighted to witness this collaboration between the Healthway Cancer Care Hospital and City of Hope. City of Hope is known to be one of the leading research and cancer treatment providers in the U.S.,” said Paolo Borromeo, president and CEO at AC Health. “Beyond this, their view on personalized and collaborative cancer care aligns strongly with our vision, and we are excited to have them work with us in extending that approach with our own medical team, ultimately benefiting our patients in the Philippines.”
This agreement is the beginning of what both institutions anticipate will be a long and fruitful collaboration. Both organizations are exploring plans for further joint initiatives to improve cancer patient outcomes and create opportunities for training and academic collaborations.
# # #
About City of Hope
City of Hope’s mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
About Healthway Medical Network
Healthway Medical Network (HMN), the provider group under AC Health, integrates the medical expertise of Healthway QualiMed Group consisting of 4 full-service hospitals and an ambulatory center, 16 Healthway Multi-Specialty Centers, and the Healthway Cancer Care Hospital. Strategically located in all parts of the country, HMN offers a wide range of medical services across the entire continuum of care.
